Eudaimonia Asset Management »

Amylyx Pharmaceuticals shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $643k 53k 12.08
2025-09-30 $1.0M 75k 13.59
2025-06-30 $641k 100k 6.41
2022-12-31 $2.4M 65k 36.95

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Commodore Capital
Saturn V Capital Management
First Light Asset Management
Goldman Sachs Group
Henderson Group
Driehaus Capital Management
Geode Capital Management
Almitas Capital
State Street Corporation

View all funds holding Amylyx Pharmaceuticals